Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03111342Phase 4Completed
Phase 4, randomised, single-blind trial of lidocaine in procedural pain (3 arms), sponsored by Universidade de São Paulo. Primary endpoint: Pain associated with LNG-IUS insertion using VAS. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03111342.